Mut. Pharm. Co. v. Bartlett, No. 12–142.

CourtUnited States Supreme Court
Writing for the CourtJustice ALITO delivered the opinion of the Court.
Citation186 L.Ed.2d 607,570 U.S. 472,133 S.Ct. 2466
Parties MUTUAL PHARMACEUTICAL CO., INC., Petitioner v. Karen L. BARTLETT.
Docket NumberNo. 12–142.
Decision Date24 June 2013
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
183 practice notes
  • City of S.F. v. Purdue Pharma L.P., Case No. 3:18-cv-07591-CRB
    • United States
    • United States District Courts. 9th Circuit. United States District Courts. 9th Circuit. Northern District of California
    • September 30, 2020
    ...accordance with their FDA labeling, both of which are preempted by the FDCA. Def. Mot. at 27-28 (citing Mut. Pharm. Co., Inc. v. Bartlett, 570 U.S. 472, 488 (2013)). In doing so, Defendants rely on the City's assertion that Defendants expressed the "false position that opioids were safe and......
  • McNair v. Johnson & Johnson, No. 17-0519
    • United States
    • Supreme Court of West Virginia
    • May 11, 2018
    ...A typical NDA spans thousands of pages and is based on clinical trials conducted over several years. Mut. Pharm. Co. v. Bartlett , 570 U.S. 472, 476-77, 133 S.Ct. 2466, 186 L.Ed.2d 607 (2013) (internal quotation marks, brackets, and citations omitted). In 1984, Congress enacted the Drug Pri......
  • Just Puppies, Inc. v. Frosh, Civil Action ELH-21-1281
    • United States
    • United States District Courts. 4th Circuit. United States District Court (Maryland)
    • September 17, 2021
    ...(observing that “‘state laws that conflict with federal law are without effect'”) (citation omitted); Mutual Pharm. Co., Inc. v. Bartlett, 570 U.S. 472, 480 (2013). “Put simply, federal law preempts contrary state law.” Hughes v. Talen Energy Mktg., LLC, ___ U.S. ___, 136 S.Ct. 1288, 1297 (......
  • Cnty. of Ocean v. Grewal, Civil Action No. 19-18083 (FLW)
    • United States
    • United States District Courts. 3th Circuit. United States District Courts. 3th Circuit. District of New Jersey
    • July 29, 2020
    ...v. Luitpold Pharms., Inc. , ––– F. Supp. 3d ––––, ––––, 2020 WL 1330705, at *3 (E.D. Pa. 2020) (quoting Mutual Pharm. Co. v. Bartlett , 570 U.S. 472, 475, 133 S.Ct. 2466, 186 L.Ed.2d 607 (2013) ). The Supreme Court has identified three categories of preemption: express preemption, conflict ......
  • Request a trial to view additional results
169 cases
  • City of S.F. v. Purdue Pharma L.P., Case No. 3:18-cv-07591-CRB
    • United States
    • United States District Courts. 9th Circuit. United States District Courts. 9th Circuit. Northern District of California
    • September 30, 2020
    ...accordance with their FDA labeling, both of which are preempted by the FDCA. Def. Mot. at 27-28 (citing Mut. Pharm. Co., Inc. v. Bartlett, 570 U.S. 472, 488 (2013)). In doing so, Defendants rely on the City's assertion that Defendants expressed the "false position that opioids were safe and......
  • McNair v. Johnson & Johnson, No. 17-0519
    • United States
    • Supreme Court of West Virginia
    • May 11, 2018
    ...A typical NDA spans thousands of pages and is based on clinical trials conducted over several years. Mut. Pharm. Co. v. Bartlett , 570 U.S. 472, 476-77, 133 S.Ct. 2466, 186 L.Ed.2d 607 (2013) (internal quotation marks, brackets, and citations omitted). In 1984, Congress enacted the Drug Pri......
  • Just Puppies, Inc. v. Frosh, Civil Action ELH-21-1281
    • United States
    • United States District Courts. 4th Circuit. United States District Court (Maryland)
    • September 17, 2021
    ...(observing that “‘state laws that conflict with federal law are without effect'”) (citation omitted); Mutual Pharm. Co., Inc. v. Bartlett, 570 U.S. 472, 480 (2013). “Put simply, federal law preempts contrary state law.” Hughes v. Talen Energy Mktg., LLC, ___ U.S. ___, 136 S.Ct. 1288, 1297 (......
  • Cnty. of Ocean v. Grewal, Civil Action No. 19-18083 (FLW)
    • United States
    • United States District Courts. 3th Circuit. United States District Courts. 3th Circuit. District of New Jersey
    • July 29, 2020
    ...v. Luitpold Pharms., Inc. , ––– F. Supp. 3d ––––, ––––, 2020 WL 1330705, at *3 (E.D. Pa. 2020) (quoting Mutual Pharm. Co. v. Bartlett , 570 U.S. 472, 475, 133 S.Ct. 2466, 186 L.Ed.2d 607 (2013) ). The Supreme Court has identified three categories of preemption: express preemption, conflict ......
  • Request a trial to view additional results
10 firm's commentaries
  • Federal Preemption of State Attempts To Ban FDA-Approved Abortion Drugs After Dobbs
    • United States
    • LexBlog United States
    • June 28, 2022
    ...of a purported state-law “stop selling” duty that the United States Supreme Court held preempted in Mutual Pharmaceutical Co. v. Bartlett, 570 U.S. 472 (2013). “Stop-selling” claims are simply: incompatible with our pre-emption jurisprudence. Our pre-emption cases presume that an actor seek......
  • Dobbs Would Likely Have Significant Impacts On Drug And Device Companies
    • United States
    • LexBlog United States
    • June 2, 2022
    ...for a drug company’s decision to market an FDA-approved medication since way since way before Mutual Pharmaceutical Co. v. Bartlett, 570 U.S. 472 (2013). (See this post on one of our decisions from 2008.) But Bartlett and its clear preemption of “stop selling” theories of liability have had......
  • Dobbs Would Likely Have Significant Impacts On Drug And Device Companies
    • United States
    • LexBlog United States
    • June 2, 2022
    ...for a drug company’s decision to market an FDA-approved medication since way since way before Mutual Pharmaceutical Co. v. Bartlett, 570 U.S. 472 (2013). (See this post on one of our decisions from 2008.) But Bartlett and its clear preemption of “stop selling” theories of liability have had......
  • Pro Se Plaintiff Tries and Fails To Plead Claims For Failure To Withdraw And Failure To Warn
    • United States
    • LexBlog United States
    • March 16, 2023
    ...some sanity. The Supreme Court provided strong assists with PLIVA v. Mensing, 564 U.S. 604 (2011), and Mutual Pharm. Co. v. Bartlett, 570 U.S. 472 (2013). Since the appellate decisions in Wimbush and Lance, few courts have expressly recognized a “stop selling” cause of action for FDA-author......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT